As of Mar 24
| +0.01 / +0.61%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 6.75, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +309.09% increase from the last price of 1.65.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.